Back to Search
Start Over
MicroRNAs as prospective biomarkers, therapeutic targets and pharmaceuticals in neuroblastoma
- Source :
- Molecular Biology Reports. 50:1895-1912
- Publication Year :
- 2022
- Publisher :
- Springer Science and Business Media LLC, 2022.
-
Abstract
- Neuroblastomas, the most prevalent malignant solid neoplasms of childhood, originate from progenitor cells of the sympathetic nervous system. Their genetic causation is diverse and involves multiple molecular mechanisms. This review highlights multiple roles of microRNA in neuroblastoma pathogenesis and discusses the prospects of harnessing these important natural regulator molecules as biomarkers, therapeutic targets and pharmaceuticals in neuroblastoma.
- Subjects :
- Genetics
General Medicine
Molecular Biology
Subjects
Details
- ISSN :
- 15734978 and 03014851
- Volume :
- 50
- Database :
- OpenAIRE
- Journal :
- Molecular Biology Reports
- Accession number :
- edsair.doi.dedup.....7a9a56da38a9544c213d5e7c577ea059